JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Caspian Journal of Internal Medicine, published by BABOL UNIVERSITY OF MEDICAL SCIENCES, serves as a significant platform for scholarly communication in the field of internal medicine. Established in 2010 and operating under an Open Access model, the journal aims to disseminate high-quality research findings and clinical insights to enhance the understanding of various internal medicine practices. With an ISSN of 2008-6164 and an E-ISSN of 2008-6172, this international journal has gained recognition, currently ranking in the Q3 category for internal medicine with a Scopus percentile of 38th, indicating its growing impact in the academic community. The journal publishes original research articles, review papers, and case reports, making it a valuable resource for researchers, healthcare professionals, and students eager to stay abreast of the latest developments in internal medicine. Situated in Iran, the journal aims to bridge gaps in knowledge and promote innovative practices in the healthcare sector. For those interested in contributing to the advancement of medicine, the Caspian Journal of Internal Medicine is a commendable choice.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

Clinics is a distinguished, peer-reviewed journal published by Elsevier España, focusing on the expansive field of medicine. Since its establishment in 1945, and transitioning to an open access model in 2005, the journal aims to disseminate high-quality research findings that contribute to the understanding of various medical disciplines. With an impressive impact factor reflected in its Q2 categorization within the miscellaneous medicine field and ranking as #124 out of 636 in general medicine according to Scopus, Clinics is recognized for its commitment to advancing medical knowledge. Researchers, healthcare professionals, and students will find invaluable insights into contemporary medical challenges and developments through its current publications extending until 2024. The journal is headquartered in Brazil, with its administrative office located at Calle de Zurbano, 76-4th Flr Left, Madrid 28010, Spain, reinforcing its strong academic presence in the international medical community.

Dubai Medical Journal, published by KARGER, is a prominent open-access journal dedicated to advancing the field of general medicine, with a keen focus on the diverse healthcare needs of the Middle Eastern region and beyond. Since its inception in 2018, the journal has provided a dynamic platform for researchers and healthcare professionals to share innovative studies and clinical insights, contributing to its recognition in the Scopus rankings, where it holds an impressive #235 out of 636, positioning it in the 63rd percentile. With a commitment to fostering global collaboration in medical research, the Dubai Medical Journal disseminates high-quality, peer-reviewed articles that span various aspects of medicine, aiming to bridge gaps in knowledge and enhance patient care. Located in Basel, Switzerland, this journal serves as an essential resource for medical practitioners, researchers, and students eager to stay abreast of contemporary developments in medical science.

Pulmonary Therapy is a leading open-access journal published by SpringerNature, dedicated to advancing the field of pulmonary and respiratory medicine as well as respiratory care. Established in 2015 and situated in the United Kingdom, the journal has rapidly gained recognition, evidenced by its impressive Q2 quartile rankings in both the Pulmonary and Respiratory Medicine and Respiratory Care categories as of 2023. With a focus on innovative research, the journal provides a platform for the dissemination of high-quality studies that address critical issues in respiratory health. Leveraging the open access model, it ensures wide dissemination and accessibility of knowledge amongst researchers, healthcare professionals, and students, thereby fostering collaborative advancements in treatment approaches and preventive care strategies. As the field continues to evolve, Pulmonary Therapy remains committed to publishing impactful scientific contributions that shape the future of respiratory medicine.

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.